JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2002; 39:790-797
© 2002 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kühlkamp, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kühlkamp, V.

CLINICAL STUDY: HEART FAILURE

Initial experience with an implantable cardioverter-defibrillator incorporating cardiac resynchronization therapy*

Volker Kühlkamp, MDa,* InSync 7272 ICD World Wide Investigators*

a Medizinische Klinik III, Tübingen, Germany

Manuscript received May 10, 2001; revised manuscript received November 21, 2001, accepted December 11, 2001.

* Reprint requests and correspondence: Dr. Volker Kühlkamp, Medizinische Klinik III, Otfried Müller Str. 10, D-72076 Tübingen, Germany.
volker.kuehlkamp{at}med.uni-tuebingen.de

OBJECTIVES: The purpose of this study was to evaluate an implantable cardioverter-defibrillator (ICD) incorporating biventricular pacing.

BACKGROUND: Biventricular pacing improves the symptoms of heart failure, a frequent problem in ICD recipients.

METHODS: This prospective multicenter study evaluated the safety and efficacy of an ICD with biventricular pacing.

RESULTS: A total of 84 patients with a standard ICD indication, symptomatic heart failure, left ventricular (LV) ejection fraction <35% and a QRS duration >130 ms were included in the trial. In 81 of 84 patients the LV lead was successfully implanted. Patients significantly improved in the 6-min hall-walk test (baseline 304 ± 131 m, three months 397 ± 142 m, p < 0.001), quality of life (baseline 38.9 ± 21.2, three months 26.5 ± 21.2, p < 0.001) and the New York Heart Association (NYHA) classification (baseline 2.8 ± 0.6, three months 2.2 ± 0.5). Left ventricular end-diastolic (from 79.6 ± 13.0 mm to 73.6 ± 12.9 mm, p = 0.002) and end-systolic (from 68.3 ± 13.5 mm to 63.9 ± 12.9 mm, p < 0.001) diameter decreased, and fractional shortening increased (from 16 ± 6% to 18 ± 6%, p = 0.018). Of the patients 26 experienced 472 episodes of spontaneous sustained ventricular tachyarrhythmias. All episodes were successfully terminated except for 16 episodes occurring in a patient with incessant ventricular tachycardia. Biventricular antitachycardia pacing was more effective than right ventricular antitachycardia pacing (p < 0.001). During follow-up (median 185 days, range 12 to 344 days) five patients died from progressive heart failure.

CONCLUSIONS: Incorporating biventricular pacing in an ICD is feasible and leads to an improvement of heart failure symptoms. Therefore, this therapy may become an option for patients who need ICD therapy in the presence of severe heart failure.

Abbreviations and Acronyms
  NYHA
  ATP
  antitachycardia pacing
  AV
  atrioventricular
  AVID
  Antiarrhythmics Versus Implantable Defibrillations study
  FVT
  fast ventricular tachycardia
  ICD
  implantable cardioverter-defibrillator
  LV
  left ventricular
  NYHA
  New York Heart Association
  RV
  right ventricular
  VF
  ventricular fibrillation
  VT
  ventricular tachycardia




This article has been cited by other articles:


Home page
EuropaceHome page
E. Nof, O. Gurevitz, S. Carraso, D. Bar-Lev, D. Luria, S. Bachar, M. Eldar, and M. Glikson
Comparison of results with different left ventricular pacing leads
Europace, January 1, 2008; 10(1): 35 - 39.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
F. A. McAlister, J. Ezekowitz, N. Hooton, B. Vandermeer, C. Spooner, D. M. Dryden, R. L. Page, M. A. Hlatky, and B. H. Rowe
Cardiac Resynchronization Therapy for Patients With Left Ventricular Systolic Dysfunction: A Systematic Review
JAMA, June 13, 2007; 297(22): 2502 - 2514.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
A. Macias, I. Garcia-Bolao, E. Diaz-Infante, J. M. Tolosana, B. Vidal, J. J. Gavira, A. Berruezo, J. Brugada, and L. Mont
Cardiac resynchronization therapy: predictive factors of unsuccessful left ventricular lead implant
Eur. Heart J., February 2, 2007; 28(4): 450 - 456.
[Abstract] [Full Text] [PDF]


Home page
Am J Crit CareHome page
S. A. Thomas, E. Friedmann, C.-W. Kao, P. Inguito, M. Metcalf, F. J. Kelley, and S. S. Gottlieb
Quality of life and psychological status of patients with implantable cardioverter defibrillators.
Am. J. Crit. Care., July 1, 2006; 15(4): 389 - 398.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
S Ellery, L Williams, and M Frenneaux
Role of resynchronisation therapy and implantable cardioverter defibrillators in heart failure
Postgrad. Med. J., January 1, 2006; 82(963): 16 - 23.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. K. Chung, L. Shemanski, D. G. Sherman, H. L. Greene, D. B. Hogan, J. C. Kellen, S. G. Kim, L. W. Martin, Y. Rosenberg, D. G. Wyse, et al.
Functional Status in Rate- Versus Rhythm-Control Strategies for Atrial Fibrillation: Results of the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Functional Status Substudy
J. Am. Coll. Cardiol., November 15, 2005; 46(10): 1891 - 1899.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
F. A. McAlister, J. A. Ezekowitz, N. Wiebe, B. Rowe, C. Spooner, E. Crumley, L. Hartling, T. Klassen, and W. Abraham
Systematic Review: Cardiac Resynchronization in Patients with Symptomatic Heart Failure
Ann Intern Med, September 7, 2004; 141(5): 381 - 390.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
S. M. Ellery and V. E. Paul
Complications of biventricular pacing
Eur. Heart J. Suppl., August 1, 2004; 6(suppl_D): D117 - D121.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. Auricchio, C. Stellbrink, C. Butter, S. Sack, J. Vogt, A. R. Misier, D. Bocker, M. Block, J. H. Kirkels, Pacing Therapies in Congestive Heart Failure (PATH, et al.
Clinical efficacy of cardiac resynchronization therapy using left ventricular pacing in heart failure patients stratified by severity of ventricular conduction delay
J. Am. Coll. Cardiol., December 17, 2003; 42(12): 2109 - 2116.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
J. P. DiMarco
Implantable Cardioverter-Defibrillators
N. Engl. J. Med., November 6, 2003; 349(19): 1836 - 1847.
[Full Text] [PDF]


Home page
Eur Heart JHome page
T. V. Salukhe, M. Y. Henein, and R. Sutton
Pacing in heart failure: patient and pacing mode selection
Eur. Heart J., June 1, 2003; 24(11): 977 - 986.
[Full Text] [PDF]


Home page
EuropaceHome page
D. A. M. J. Theuns, J. C. J. Res, and L. J. Jordaens
Home monitoring in ICD therapy: future perspectives
Europace, January 1, 2003; 5(2): 139 - 142.
[Abstract] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2002 by the American College of Cardiology Foundation.